Juul receives approval for second device
Juul FDA approval clears the Juul2 e‑cigarette and menthol and tobacco pods, adding app integration and safety controls that could attract cautious vapers.
Juul Labs has secured marketing approval from the U.S. Food and Drug Administration for its Juul2 e‑cigarette device and two flavored pods, according to a Friday press release. The agency granted the green light to the Juul2 as well as menthol and tobacco‑flavored pods for use with the product.
New device features app integration and safety controls
The Juul2 was initially submitted to the FDA in 2023. The device pairs with a gated smartphone app that provides insights into consumers’ product use, device location, real‑time battery levels, and other information. A device lock on the app keeps the Juul2 from being used by anyone its owner hasn’t authorized.
Beyond basic connectivity, the app creates a secure link that only allows verified owners to activate the device, effectively establishing a personal usage profile. This profile records each puff count and can alert the user when the pod is nearing depletion, helping to manage nicotine intake more precisely. The location‑tracking feature also enables owners to locate a misplaced device through the app’s interface.
The device includes a more consistent vapor and nicotine delivery system. It also features an improved heat control system and pod IDs to prevent the use of illegal counterfeit pods. The product has been available in other countries, but the latest marketing approval allows the manufacturer to bring it to the U.S. market.
Heat control is managed by an internal sensor that adjusts power output in response to pod resistance, which smooths the transition between draws and reduces the likelihood of overheating. Pod identification relies on a digital signature embedded in each legitimate cartridge; the device reads this signature before activating, ensuring that only authorized pods can generate vapor. This safeguard directly addresses concerns about counterfeit products that have previously entered the market.
Juul sees opportunity amid market decline
As combustible cigarette use continues to dwindle, more focus is turning toward other nicotine products, like e‑cigarettes and nicotine pouches. Juul was the second‑biggest e‑cigarette brand in the U.S. by sales for the year that ended July 27, according to a recent Goldman Sachs report that cited NielsenIQ data. Juul sales had seen declines of 1.6% year over year, which was better than the nearly 12% declines for the category as a whole.
With Juul reporting that a significant percentage of Juul2 users have switched away from combustible cigarettes — including up to 49% of those using its menthol‑flavored pods — the company is eyeing a return to growth. This shift in consumer behavior is becoming a central focus for manufacturers trying to handle a saturated market.
Related: Convenience Stores Brace for College Football Surge
The transition from traditional cigarettes to a device that can be monitored through a smartphone aligns with broader trends toward digital health management. Users who track their usage can set limits, receive notifications when they approach predefined thresholds, and even share data with healthcare providers if they choose. Such capabilities differentiate the Juul2 from earlier generations that offered limited feedback.
Juul’s ability to demonstrate that a sizable share of its new‑pod users have already abandoned combustible products strengthens its case for continued investment in product innovation. The company’s data suggests that the menthol pod, in particular, resonates with former smokers seeking a familiar flavor profile while benefiting from the device’s safety features.
Juul, which was granted marketing approval for its first e‑cigarette device in 2025, is one of five companies whose vaping products have received the FDA’s green light, according to the administration’s website. The others are Glas, Logic Technology Development, Njoy and R.J. Reynolds Vapor Company.
The limited number of approved manufacturers shows the regulatory rigor applied to the sector. Each firm must satisfy the FDA’s standards for product composition, manufacturing practices, and consumer safeguards before a product can enter the U.S. market. By joining this exclusive group, Juul not only secures a foothold but also gains credibility among retailers and consumers who are increasingly attentive to compliance.
Internationally, the Juul2 had already been sold in markets with established vaping frameworks, allowing the company to refine the device based on real‑world performance before seeking U.S. clearance. Feedback from those markets informed enhancements such as the heat‑control algorithm and the pod‑identification protocol, which now form core components of the U.S. offering.
Looking ahead, the combination of app‑driven data, robust safety mechanisms, and a product line that includes menthol and tobacco flavors positions Juul to capture a segment of former smokers who are migrating to regulated nicotine alternatives. The approval marks a key moment that could reshape the competitive trends of a category that has faced both declining overall volume and heightened scrutiny.
